IP Library Granted Patent US 9,994,845
Granted Patent B2
US 9,994,845 · App. 15/023,869 · Granted Jun 12, 2018

Methods and compositions to inhibit metastasis and to treat fibrosis and to enhance wound healing

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,994,845
App. No.
15/023,869
Granted
Jun 12, 2018
Kind
B2
Abstract

Methods and compositions are provided for inhibiting or treating metastasis based on discoveries regarding Kif19 and Cep192. Methods and compositions are provided for enhancing wound healing, treating fibrosis, reducing scarring and treating nerve pain.

Claims (11)

1. A method of treating metastasis or inhibiting metastasis in a subject having anaplastic thyroid carcinoma comprising administering to the subject an amount of an siRNA or shRNA inhibitor of KIF19 effective to treat metastasis or inhibit metastasis.

2. A method of treating fibrosis or scarring, or of inhibiting fibrosis or scarring, in a subject comprising administering to the subject an amount of an siRNA or shRNA inhibitor of KIF19 effective to treat fibrosis or scarring, or inhibit fibrosis or scarring.

3. The method of claim 1 , wherein the KIF19 is a human KIF 19.

4. The method of claim 1 , wherein a siRNA directed to KIF19 is administered.

5. The method of claim 1 , wherein a shRNA directed to KIF19 is administered.

6. The method of claim 4 , wherein the siRNA is administered as a composition comprising the siRNA associated with a nanoparticle.

7. The method of claim 5 , wherein the shRNA is administered as a composition comprising the shRNA encapsulated with a nanoparticle.

8. The method of claim 6 , wherein the nanoparticle is PEGylated.

9. The method of claim 4 , wherein the siRNA is administered as a viral vector.

10. The method of claim 5 , wherein the shRNA is administered as a viral vector.

11. The method of claim 2 , wherein the fibrosis is in response to an injury.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2024
From: RATH, UTTAMA
To: ALBERT EINSTEIN COLLEGE OF MEDICINE
Reel/Frame 066243/0131 →
MERGER AND CHANGE OF NAME Recorded Feb 26, 2019
From: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.; ALBERT EINSTEIN COLLEGE OF MEDICINE
To: ALBERT EINSTEIN COLLEGE OF MEDICINE
Reel/Frame 048438/0275 →